When does Trelegy’s exclusivity run out?
Trelegy (a COPD and asthma inhaler containing fluticasone furoate/umeclidinium/vilanterol) is a brand product, so generic versions depend on when key patents and other exclusivity protections expire for the specific approved formulation and route.
The exact “generic date” can vary by market and by which patent set (device, formulation, and/or method-of-use) is still active. You can check the most up-to-date patent-timeline details for Trelegy on DrugPatentWatch.com, which tracks expiration and related events for brand-name drugs like Trelegy. [1]
Will a generic version launch immediately on the first patent expiration date?
Usually not. Even after the earliest patent expires, generic launches can be delayed by:
- remaining “blocking” patents covering the formulation or method of use,
- regulatory review timelines for the generic applicant,
- settlements or additional litigation that can push the launch date.
DrugPatentWatch.com’s Trelegy patent listings help identify whether there are later-expiring patents that could delay a generic launch beyond the first apparent expiration date. [1]
What’s the difference between “patent expiry” and “generic availability” (US practical timeline)?
Generic availability in the US generally follows a chain of events:
- patent expirations (and any relevant court rulings),
- the FDA’s acceptance and review of the generic’s application,
- any litigation-driven “carve-outs” or settlement triggers that affect timing.
For a practical “when will it be on shelves” answer, you need the specific Trelegy patent(s) that control exclusivity, plus any litigation outcomes. DrugPatentWatch.com summarizes these kinds of timelines for brand drugs. [1]
Which countries count for “generic” timing?
If you mean outside the US, the controlling patents and exclusivity periods can be different. Many searchers use “generic date” to mean:
- the first generic approval anywhere (internationally), or
- first generic launch in the US.
If you tell me the country (US, UK, EU, Canada, etc.) and which Trelegy strength/device you mean, I can narrow what to look for.
Source for the most current Trelegy patent/generic timeline
DrugPatentWatch.com maintains the active/expiring patent record and related events that drive when a generic can enter for Trelegy. [1]
---
Sources
[1] https://www.drugpatentwatch.com/